Andros Pharmaceuticals

Novel drug delivery platforms advancing topical and liposomal therapeutics

Andros Pharmaceuticals is a biotech company in Zhubei City, Taiwan, founded in 2008.

Headquarters
Zhubei City
Employees
11–50
Founded
2008
Business Model
B2B

About

Andros Pharmaceuticals Co., Ltd. (Andros Pharma) is a biopharmaceutical company founded in 2008 and headquartered in Zhubei City, Hsinchu County, Taiwan. Founded by Dr. Ae-June Wang, who serves as President and CEO, the company specializes in developing novel drug delivery platform technologies with a focus on lipid encapsulation, liposomal formulations, and innovative topical dosage forms. Andros Pharma's core competency lies in advanced drug delivery systems that improve efficacy and safety of existing pharmaceutical compounds. The company achieved a landmark regulatory milestone with the first-ever new dosage form approval in Taiwan and holds a GMP/GDP license from the Taiwan FDA. Andros established an Australian subsidiary in 2017 and collaborates with international pharmaceutical partners. The company targets specialty pharmaceutical markets including dermatology and topical therapeutics, with a team of researchers spanning pharmacy, chemistry, chemical engineering, and molecular biology.

Summary

It lists 11–50 employees.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Andros Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/andros-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/andros-pharmaceuticals" alt="Andros Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>